During the past trading week (September 23 to 27), a beneficial bill for the marijuana industry became the first approved cannabis-related legislation in US Congress.
Also making headlines was a cannabis producer that may be gaining following the biggest scandal in the Canadian market, as well as highlights from the recent MoneyShow event in Toronto.
Here’s a closer look at some of the biggest cannabis news over the last week.
SAFE Act gains House support, now faces Senate
After months of political process, on Wednesday (September 25) the US House of Representatives approved the Secure and Fair Enforcement Banking Act of 2019, known as the SAFE Banking Act.
This vote has moved the bill to the Senate, where it is expected to face a steep battle towards approval.
“I think the market realizes that one of the biggest hurdles remains — the Senate — and there’s nothing really concrete there yet,” Matthew Pallotta, equity research analyst at Echelon Wealth Partners, told the Investing News Network (INN).
The latest edition of the MoneyShow conference in Toronto gave investors a chance to take stock of the landscape for cannabis, as a variety of critical developments loom in the horizon. Investors who missed the event can catch up with our dispatch on the talks from the show.
A joint talk between CIBC Capital Markets’ John Zamparo and Horizons ETFs Management (Canada) CEO Steve Hawkins explored the relationship between the Canadian and US cannabis investment markets.
Zamparo identified the upcoming legalization of edibles and infused products in Canada as a potential driver for the market, while in the US, the catalysts for the stock market are attached to the development of critical bills that would help the overall industry.
Pitfalls open the doors for other producers in Canada
Canadian cannabis producer Aleafia Health (TSX:ALEF,OTCQX:ALEAF) recently announced it has reached 10,000 active patients. The firm told INN it has been able to take advantage of the failings of its peers.
“We’re extremely focused on our patients and making sure that they get the product that they deserve, so if another (licensed producer) is not able to deliver that to them, we want to make sure that we give them the opportunity to continue their care, and we’re well positioned for that,” said Benjamin Ferdinand, CFO of Aleafia Health.
Cannabis patients in Canada were rocked when CannTrust Holdings (NYSE:CTST,TSX:TRST) admitted to unlicensed growing in July. The firm served 68,000 patients in the country.
Aleafia Health told INN it has experienced exponential growth in its patient count during August and September.
Skateboarding retailer embraces CBD products
This past week, the acceptance of CBD products for consumers in the US increased thanks to a new partnership between 1933 Industries (CSE:TGIF,OTCQX:TGIFF) and Zumiez (NASDAQ:ZUMZ), a specialty retailer selling clothing and skateboards.
The partnership will bring the introduction of Canna Hemp X, a CBD sports recovery cream. More products will be made available later on, according to the two companies.
In a statement, Paul Kobriger, brand manager for Canna Hemp X, said Zumiez has a special approach to the marketing of products for customers interested in action sports.
“Zumiez offers unique, emerging and trending brands that reflect a passion for an active lifestyle.”
“We think … (Ayr) should be trading at a much higher multiple relative to the comparables, and so, given the price action, we think this is a great time to be buying back what we think is one of the cheapest stocks in the sector,” Jennifer Drake, Ayr’s chief operating officer, told INN.
According to Jonathan Sandelman, CEO of Ayr, the firm will be able to conduct this purchase thanks to a recent uptick in cash flow generated from operations.
A company planning a future public listing announced the launch of a new credit card program for US cannabis consumers. Thomas Gavin IV, CEO of CannaCard, told INN his company aims to offer some relief to the cash-only options available to dispensaries and consumers.
The card is only available in Colorado, but the firm is planning a national expansion starting in October.
CIBC Capital Markets issued new research notes for players of the Canadian marijuana industry. On Monday (September 23), the bank kicked off its coverage of Aurora Cannabis (NYSE:ACB,TSX:ACB), The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) and Organigram Holdings (NASDAQ:OGI,TSXV:OGI).
The firm awarded Supreme Cannabis and Organigram “outperformer” ratings, while Aurora obtained a “neutral” rating for its stock.
The marijuana market was well represented as part of a new best-performing stocks list from the Toronto Stock Exchange (TSX). The TSX30 list was designed to highlight companies with the best stock performance over the past three years. Below are the cannabis-related stocks that made it and their rankings on the list:
- Canopy Growth (NYSE:CGC,TSX:WEED) — First place
- Shopify (NYSE:SHOP,TSX:SHOP) — Second place
- Village Farms International (NASDAQ:VFF,TSX:VFF) — Third place
- Aphria (NYSE:APHA,TSX:APHA) — Sixth place
- Neptune Wellness Solutions (NASDAQ:NEPT,TSX:NEPT) — Eighth place
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: 1933 Industries is a client of the Investing News Network. This article is not paid-for content.